Cambridge Nucleomics
Single-molecule nucleic acid biomarker detection in one-pot reactions for time-critical clinical decisions
Highlights
- New on EvolcAdded 2026-11-11
About Cambridge Nucleomics
Cambridge Nucleomics develops a rapid single-molecule detection technology for high-plex nucleic acid biomarkers, run as a single one-pot reaction. The stated purpose is supporting time-critical clinical decisions.
The company was founded by Dr Hendrik Runge, who serves as Founder and CEO, and Prof Ulrich Keyser, its scientific founder and the inventor of the core single-molecule RNA counting nanoarray assay.
The company is incorporated in the United Kingdom, with its registered seat in Cambridge, and was founded in 2021. Its scientific team covers nanotechnology, RNA biology and microbiology, and its board includes Dr Anthony Cooke as Chairman.
Product: High-plex single-molecule nucleic acid biomarker detection, performed in a single one-pot reaction.
Jobs at Cambridge Nucleomics
Leadership
- Ulrich Keyser · Scientific founderSource: company website
- Hendrik Runge · Founder & CEOSource: company website
More health & medtech companies
Cambridge Nursing Home
Residential and nursing care for older people in Wanstead, East London, with a CQC-rated homeNew on EvolcCamelot Care (Somerset)
Nursing and dementia care homes for older people in Somerset and Devon, EnglandNew on EvolcCamino Healthcare
Mental health and learning disability rehabilitation for adults with complex care needsCancerresearchuk
Charity funding cancer research and providing cancer information to the public across the UKNew on EvolcCancheck
Medical cannabis education and comparison platform for patients in the UK and EuropeYoung companyNew on EvolcCanine Health & Hydro
Canine hydrotherapy and rehabilitation services for dogs and other pets in LancashireNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-amz-cf-id
- Response headerx-amz-cf-id
- Response headerx-amz-cf-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.